Life Sciences division connecting with medical device and drug companies to improve diabetes care...
Read More »Managing Editor, Diabetes in Control
How Type 2 Diabetes is Linked with Alzheimer’s Disease
T2 patients may be at increased risk of developing tangles in the brain that indicate dementia.
Read More »New Data to Analyze Trends in Diabetes
Plateaus mark possibly better screening methods, survival among diagnosed patients...
Read More »The Value of the Nitric Oxide Pathway and its Importance in African-American Patients with Heart Failure
Studies in heart failure and hypertension have shown that people who identify themselves as black may have a less active renin-angiotensin system and a lower bioavailability of nitric oxide. The A-HeFT study was conducted to determine if a fixed dose of isosorbide dinitrate (ISDN) and hydralazine would provide additional benefit in black patients with heart failure.
Read More »Editor’s Note – DCMS-258
I was reading this week’s Clinical Gem about the use of diuretics for reducing heart failure and blood pressure values. There was a mention of the differences in responses among certain ethnic groups and the difficulty that we often have with African-American patients. There was a lot of focus on …
Read More »Play It Safe With at Least TWO Pharmacies
With the prevalence of mail-order pharmacies, I’ve always recommended that my patients use their local pharmacy for at least one prescription. Why? If an emergency arises, and they need a medication or supplies right away, they can get great service locally because they have established a relationship
Read More »Dragon Dictation
Dragon Dictation is an easy-to-use voice recognition application powered by Dragon® NaturallySpeaking® that allows you to easily speak and instantly see your text or email messages. In fact, it’s up to five (5) times faster than typing on the keyboard. Features: Voice-to-text transcriptions that may be sent as SMS, Email, …
Read More »Test Your Knowledge Question #798
A 43-year old patient with a 2-year history of type 2 diabetes presents to your office for a follow-up visit. She is a highly motivated patient and doesn’t have any significant co-morbidities, so together, you have set a target A1C= 6.5%. Her current medications are metformin and sulfonylurea. Despite her good efforts, her current A1C is 7.3%. You would like to add a third agent to her regimen, however she is concerned about any additional weight gain as she has gained a few pounds since starting the sulfonylurea. Which drug class would you add to minimize any additional weight gain? A. Basal insulin B. GLP-1 agonist C. Thiazolidine D. DPP-4 Inhibitor Follow link to take the test!
Read More »Beware: Diabetes Results in Significant Electrolyte Disturbances
Incidence of type 2 diabetes is increasing rapidly. It accounts for up to half of all cases of new-onset diabetes in young people. Dysfunction in glucose homeostasis impacts acid-base regulation. In addition, injury to organs as a result of diabetes and antidiabetic drugs contribute to this dysregulation. Hyponatremia is associated …
Read More »Imperium: World’s First Instant Insulin Patch
Unilife Corporation has launched the world’s first instant insulin patch, Imperium. Imperium is a prefilled, preassembled, multi-day wearable insulin pump for continuous subcutaneous insulin infusion and on-demand bolus delivery through the push of a button. It is equipped with Bluetooth connectivity to wirelessly connect with smartphone apps for patient reminders …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.